nodes	percent_of_prediction	percent_of_DWPC	metapath
Verapamil—ABCB11—Progesterone—uterine cancer	0.0593	0.0807	CbGbCtD
Verapamil—ABCC10—Etoposide—uterine cancer	0.0488	0.0664	CbGbCtD
Verapamil—ABCC1—Progesterone—uterine cancer	0.0421	0.0573	CbGbCtD
Verapamil—ABCC1—Dactinomycin—uterine cancer	0.0334	0.0455	CbGbCtD
Verapamil—ABCC10—Doxorubicin—uterine cancer	0.0333	0.0453	CbGbCtD
Verapamil—SLC22A1—Progesterone—uterine cancer	0.0332	0.0451	CbGbCtD
Verapamil—SLC22A5—Dactinomycin—uterine cancer	0.0318	0.0432	CbGbCtD
Verapamil—ABCC3—Etoposide—uterine cancer	0.0307	0.0418	CbGbCtD
Verapamil—ABCC1—Epirubicin—uterine cancer	0.0242	0.0329	CbGbCtD
Verapamil—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0227	0.0308	CbGbCtD
Verapamil—ABCG2—Dactinomycin—uterine cancer	0.0224	0.0304	CbGbCtD
Verapamil—ABCC3—Doxorubicin—uterine cancer	0.021	0.0285	CbGbCtD
Verapamil—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.0208	0.0283	CbGbCtD
Verapamil—CYP3A7—Progesterone—uterine cancer	0.0208	0.0283	CbGbCtD
Verapamil—ABCC1—Etoposide—uterine cancer	0.0189	0.0257	CbGbCtD
Verapamil—ABCB11—Doxorubicin—uterine cancer	0.0181	0.0246	CbGbCtD
Verapamil—ABCC2—Carboplatin—uterine cancer	0.0166	0.0226	CbGbCtD
Verapamil—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0158	0.0215	CbGbCtD
Verapamil—CYP3A5—Progesterone—uterine cancer	0.0156	0.0213	CbGbCtD
Verapamil—ABCG2—Carboplatin—uterine cancer	0.015	0.0204	CbGbCtD
Verapamil—CYP2C8—Progesterone—uterine cancer	0.015	0.0204	CbGbCtD
Verapamil—ABCC2—Etoposide—uterine cancer	0.014	0.019	CbGbCtD
Verapamil—ABCC1—Doxorubicin—uterine cancer	0.0129	0.0175	CbGbCtD
Verapamil—ABCG2—Etoposide—uterine cancer	0.0126	0.0172	CbGbCtD
Verapamil—CYP2C19—Progesterone—uterine cancer	0.0126	0.0171	CbGbCtD
Verapamil—CYP1A2—Progesterone—uterine cancer	0.0116	0.0158	CbGbCtD
Verapamil—CYP2C9—Progesterone—uterine cancer	0.0105	0.0143	CbGbCtD
Verapamil—ABCB1—Progesterone—uterine cancer	0.0102	0.0138	CbGbCtD
Verapamil—CYP2D6—Progesterone—uterine cancer	0.00958	0.013	CbGbCtD
Verapamil—ABCC2—Doxorubicin—uterine cancer	0.00952	0.013	CbGbCtD
Verapamil—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0092	0.0125	CbGbCtD
Verapamil—ABCG2—Doxorubicin—uterine cancer	0.00861	0.0117	CbGbCtD
Verapamil—ABCB1—Dactinomycin—uterine cancer	0.00806	0.011	CbGbCtD
Verapamil—CYP3A5—Etoposide—uterine cancer	0.00699	0.00951	CbGbCtD
Verapamil—CYP2C8—Etoposide—uterine cancer	0.00672	0.00914	CbGbCtD
Verapamil—CYP3A4—Progesterone—uterine cancer	0.00609	0.00829	CbGbCtD
Verapamil—CYP2B6—Doxorubicin—uterine cancer	0.00605	0.00823	CbGbCtD
Verapamil—CYP1A2—Etoposide—uterine cancer	0.0052	0.00708	CbGbCtD
Verapamil—ABCB1—Etoposide—uterine cancer	0.00455	0.00619	CbGbCtD
Verapamil—ABCB1—Doxorubicin—uterine cancer	0.0031	0.00422	CbGbCtD
Verapamil—CYP2D6—Doxorubicin—uterine cancer	0.00292	0.00398	CbGbCtD
Verapamil—CYP3A4—Etoposide—uterine cancer	0.00273	0.00371	CbGbCtD
Verapamil—CYP3A4—Doxorubicin—uterine cancer	0.00186	0.00253	CbGbCtD
Verapamil—CACNB3—myometrium—uterine cancer	0.00171	0.0244	CbGeAlD
Verapamil—CACNA1G—decidua—uterine cancer	0.00138	0.0197	CbGeAlD
Verapamil—CACNB3—uterine cervix—uterine cancer	0.00133	0.019	CbGeAlD
Verapamil—CACNB3—decidua—uterine cancer	0.00127	0.0181	CbGeAlD
Verapamil—CACNA1H—myometrium—uterine cancer	0.00122	0.0174	CbGeAlD
Verapamil—CACNB3—endometrium—uterine cancer	0.0012	0.0172	CbGeAlD
Verapamil—CACNB4—vagina—uterine cancer	0.00118	0.0168	CbGeAlD
Verapamil—CACNB3—mammalian vulva—uterine cancer	0.00117	0.0166	CbGeAlD
Verapamil—CACNB3—uterus—uterine cancer	0.00111	0.0158	CbGeAlD
Verapamil—CYP2C18—uterine cervix—uterine cancer	0.00106	0.0151	CbGeAlD
Verapamil—CACNB3—female reproductive system—uterine cancer	0.000998	0.0142	CbGeAlD
Verapamil—CACNB1—female gonad—uterine cancer	0.000947	0.0135	CbGeAlD
Verapamil—CYP2C18—mammalian vulva—uterine cancer	0.000928	0.0132	CbGeAlD
Verapamil—CACNA1C—myometrium—uterine cancer	0.000928	0.0132	CbGeAlD
Verapamil—CACNA1I—lymph node—uterine cancer	0.000926	0.0132	CbGeAlD
Verapamil—CACNA1H—smooth muscle tissue—uterine cancer	0.000921	0.0131	CbGeAlD
Verapamil—CACNB3—female gonad—uterine cancer	0.000908	0.0129	CbGeAlD
Verapamil—CACNB3—vagina—uterine cancer	0.000903	0.0129	CbGeAlD
Verapamil—ABCC10—myometrium—uterine cancer	0.00084	0.012	CbGeAlD
Verapamil—CACNA1H—uterus—uterine cancer	0.00079	0.0113	CbGeAlD
Verapamil—SLC22A4—myometrium—uterine cancer	0.00079	0.0113	CbGeAlD
Verapamil—CACNA1D—uterine cervix—uterine cancer	0.000782	0.0111	CbGeAlD
Verapamil—CYP2C18—vagina—uterine cancer	0.000719	0.0102	CbGeAlD
Verapamil—CACNA1B—lymph node—uterine cancer	0.00071	0.0101	CbGeAlD
Verapamil—CACNA1H—female reproductive system—uterine cancer	0.00071	0.0101	CbGeAlD
Verapamil—CACNA1C—smooth muscle tissue—uterine cancer	0.000702	0.01	CbGeAlD
Verapamil—CACNA1C—decidua—uterine cancer	0.000688	0.0098	CbGeAlD
Verapamil—ABCC10—uterine cervix—uterine cancer	0.000654	0.00931	CbGeAlD
Verapamil—SLCO1B1—renal system—uterine cancer	0.000648	0.00923	CbGeAlD
Verapamil—CACNA1H—female gonad—uterine cancer	0.000646	0.00921	CbGeAlD
Verapamil—KCNJ11—female reproductive system—uterine cancer	0.000636	0.00907	CbGeAlD
Verapamil—ABCC3—decidua—uterine cancer	0.000626	0.00892	CbGeAlD
Verapamil—ABCC10—decidua—uterine cancer	0.000623	0.00887	CbGeAlD
Verapamil—ABCC3—renal system—uterine cancer	0.000614	0.00876	CbGeAlD
Verapamil—ABCC10—renal system—uterine cancer	0.000611	0.00871	CbGeAlD
Verapamil—CACNB1—lymph node—uterine cancer	0.000609	0.00867	CbGeAlD
Verapamil—CACNB2—vagina—uterine cancer	0.000606	0.00864	CbGeAlD
Verapamil—ABCC1—myometrium—uterine cancer	0.000594	0.00847	CbGeAlD
Verapamil—ABCC10—endometrium—uterine cancer	0.000591	0.00842	CbGeAlD
Verapamil—SLC22A4—decidua—uterine cancer	0.000585	0.00834	CbGeAlD
Verapamil—CACNB3—lymph node—uterine cancer	0.000584	0.00832	CbGeAlD
Verapamil—KCNJ11—female gonad—uterine cancer	0.000579	0.00825	CbGeAlD
Verapamil—SLC22A4—renal system—uterine cancer	0.000575	0.00819	CbGeAlD
Verapamil—ABCC10—mammalian vulva—uterine cancer	0.000572	0.00815	CbGeAlD
Verapamil—SLC22A4—endometrium—uterine cancer	0.000556	0.00792	CbGeAlD
Verapamil—KCNH2—myometrium—uterine cancer	0.000553	0.00788	CbGeAlD
Verapamil—SLC22A1—renal system—uterine cancer	0.000547	0.0078	CbGeAlD
Verapamil—ABCC10—uterus—uterine cancer	0.000545	0.00776	CbGeAlD
Verapamil—CACNA1C—female reproductive system—uterine cancer	0.000541	0.00771	CbGeAlD
Verapamil—SLCO1A2—renal system—uterine cancer	0.000527	0.00751	CbGeAlD
Verapamil—SLC22A5—myometrium—uterine cancer	0.000522	0.00745	CbGeAlD
Verapamil—SLCO1B1—female reproductive system—uterine cancer	0.000519	0.00739	CbGeAlD
Verapamil—ABCC4—renal system—uterine cancer	0.000507	0.00723	CbGeAlD
Verapamil—ABCC3—female reproductive system—uterine cancer	0.000492	0.00701	CbGeAlD
Verapamil—ABCG2—myometrium—uterine cancer	0.000492	0.00701	CbGeAlD
Verapamil—ABCC2—renal system—uterine cancer	0.000491	0.007	CbGeAlD
Verapamil—ABCC10—female reproductive system—uterine cancer	0.00049	0.00698	CbGeAlD
Verapamil—CACNA1C—vagina—uterine cancer	0.000489	0.00697	CbGeAlD
Verapamil—SCN5A—vagina—uterine cancer	0.000474	0.00676	CbGeAlD
Verapamil—ABCC1—uterine cervix—uterine cancer	0.000462	0.00659	CbGeAlD
Verapamil—SLC22A4—female reproductive system—uterine cancer	0.00046	0.00656	CbGeAlD
Verapamil—ABCC4—uterus—uterine cancer	0.000452	0.00644	CbGeAlD
Verapamil—ABCC3—female gonad—uterine cancer	0.000448	0.00638	CbGeAlD
Verapamil—ABCC10—female gonad—uterine cancer	0.000446	0.00635	CbGeAlD
Verapamil—ABCC10—vagina—uterine cancer	0.000443	0.00631	CbGeAlD
Verapamil—ABCC1—decidua—uterine cancer	0.00044	0.00628	CbGeAlD
Verapamil—KCNH2—uterine cervix—uterine cancer	0.00043	0.00613	CbGeAlD
Verapamil—ABCC1—endometrium—uterine cancer	0.000418	0.00596	CbGeAlD
Verapamil—SLC22A4—vagina—uterine cancer	0.000416	0.00593	CbGeAlD
Verapamil—CACNA1H—lymph node—uterine cancer	0.000415	0.00592	CbGeAlD
Verapamil—SLC6A4—female reproductive system—uterine cancer	0.000408	0.00581	CbGeAlD
Verapamil—SLC22A5—uterine cervix—uterine cancer	0.000407	0.00579	CbGeAlD
Verapamil—ABCC4—female reproductive system—uterine cancer	0.000406	0.00579	CbGeAlD
Verapamil—ABCC1—mammalian vulva—uterine cancer	0.000404	0.00576	CbGeAlD
Verapamil—KCNH2—renal system—uterine cancer	0.000402	0.00574	CbGeAlD
Verapamil—SLC22A1—vagina—uterine cancer	0.000396	0.00565	CbGeAlD
Verapamil—ABCC2—female reproductive system—uterine cancer	0.000393	0.0056	CbGeAlD
Verapamil—CACNB2—lymph node—uterine cancer	0.000392	0.00559	CbGeAlD
Verapamil—KCNH2—endometrium—uterine cancer	0.000389	0.00555	CbGeAlD
Verapamil—ABCC1—uterus—uterine cancer	0.000385	0.00549	CbGeAlD
Verapamil—ABCG2—uterine cervix—uterine cancer	0.000383	0.00545	CbGeAlD
Verapamil—SLC22A5—renal system—uterine cancer	0.00038	0.00542	CbGeAlD
Verapamil—KCNJ11—lymph node—uterine cancer	0.000372	0.0053	CbGeAlD
Verapamil—ABCC4—female gonad—uterine cancer	0.00037	0.00527	CbGeAlD
Verapamil—CYP2C8—renal system—uterine cancer	0.000368	0.00525	CbGeAlD
Verapamil—SLC22A5—endometrium—uterine cancer	0.000368	0.00524	CbGeAlD
Verapamil—ABCG2—decidua—uterine cancer	0.000365	0.0052	CbGeAlD
Verapamil—KCNH2—uterus—uterine cancer	0.000359	0.00511	CbGeAlD
Verapamil—CYP2C8—endometrium—uterine cancer	0.000356	0.00507	CbGeAlD
Verapamil—CYP3A5—uterine cervix—uterine cancer	0.000355	0.00506	CbGeAlD
Verapamil—ABCG2—endometrium—uterine cancer	0.000346	0.00493	CbGeAlD
Verapamil—CYP1A2—renal system—uterine cancer	0.000345	0.00491	CbGeAlD
Verapamil—CACNA1D—lymph node—uterine cancer	0.000343	0.00489	CbGeAlD
Verapamil—ABCG2—mammalian vulva—uterine cancer	0.000335	0.00477	CbGeAlD
Verapamil—CYP3A5—renal system—uterine cancer	0.000332	0.00474	CbGeAlD
Verapamil—CYP2B6—renal system—uterine cancer	0.00033	0.00471	CbGeAlD
Verapamil—Dyspnoea—Progesterone—uterine cancer	0.000327	0.00288	CcSEcCtD
Verapamil—Shock—Medroxyprogesterone Acetate—uterine cancer	0.000327	0.00288	CcSEcCtD
Verapamil—Somnolence—Progesterone—uterine cancer	0.000326	0.00287	CcSEcCtD
Verapamil—Bronchospasm—Etoposide—uterine cancer	0.000325	0.00286	CcSEcCtD
Verapamil—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000324	0.00286	CcSEcCtD
Verapamil—Dyspepsia—Progesterone—uterine cancer	0.000323	0.00284	CcSEcCtD
Verapamil—Alopecia—Dactinomycin—uterine cancer	0.000322	0.00284	CcSEcCtD
Verapamil—KCNH2—female reproductive system—uterine cancer	0.000322	0.00459	CbGeAlD
Verapamil—Sweating increased—Etoposide—uterine cancer	0.000321	0.00283	CcSEcCtD
Verapamil—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.000321	0.00283	CcSEcCtD
Verapamil—ABCG2—uterus—uterine cancer	0.000319	0.00455	CbGeAlD
Verapamil—CACNA1C—lymph node—uterine cancer	0.000316	0.00451	CbGeAlD
Verapamil—Fatigue—Progesterone—uterine cancer	0.000316	0.00279	CcSEcCtD
Verapamil—ABCC1—female gonad—uterine cancer	0.000315	0.00449	CbGeAlD
Verapamil—Constipation—Progesterone—uterine cancer	0.000314	0.00276	CcSEcCtD
Verapamil—Pain—Progesterone—uterine cancer	0.000314	0.00276	CcSEcCtD
Verapamil—ABCC1—vagina—uterine cancer	0.000313	0.00446	CbGeAlD
Verapamil—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000311	0.00274	CcSEcCtD
Verapamil—CYP2C19—vagina—uterine cancer	0.000306	0.00435	CbGeAlD
Verapamil—SLC22A5—female reproductive system—uterine cancer	0.000305	0.00434	CbGeAlD
Verapamil—Atrioventricular block—Epirubicin—uterine cancer	0.000304	0.00268	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000303	0.00267	CcSEcCtD
Verapamil—Feeling abnormal—Progesterone—uterine cancer	0.000302	0.00266	CcSEcCtD
Verapamil—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000301	0.00265	CcSEcCtD
Verapamil—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000298	0.00263	CcSEcCtD
Verapamil—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000296	0.00261	CcSEcCtD
Verapamil—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000295	0.0026	CcSEcCtD
Verapamil—CYP2C8—female reproductive system—uterine cancer	0.000295	0.0042	CbGeAlD
Verapamil—KCNH2—female gonad—uterine cancer	0.000293	0.00418	CbGeAlD
Verapamil—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000293	0.00258	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.000292	0.00257	CcSEcCtD
Verapamil—KCNH2—vagina—uterine cancer	0.000292	0.00415	CbGeAlD
Verapamil—Urticaria—Progesterone—uterine cancer	0.000291	0.00257	CcSEcCtD
Verapamil—Acute coronary syndrome—Etoposide—uterine cancer	0.00029	0.00255	CcSEcCtD
Verapamil—Myocardial infarction—Etoposide—uterine cancer	0.000288	0.00254	CcSEcCtD
Verapamil—ABCC3—lymph node—uterine cancer	0.000288	0.0041	CbGeAlD
Verapamil—Jaundice—Etoposide—uterine cancer	0.000287	0.00253	CcSEcCtD
Verapamil—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000287	0.00252	CcSEcCtD
Verapamil—ABCC10—lymph node—uterine cancer	0.000286	0.00408	CbGeAlD
Verapamil—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000284	0.0025	CcSEcCtD
Verapamil—Atrioventricular block—Doxorubicin—uterine cancer	0.000281	0.00248	CcSEcCtD
Verapamil—SLC22A5—female gonad—uterine cancer	0.000277	0.00395	CbGeAlD
Verapamil—SLC22A5—vagina—uterine cancer	0.000276	0.00393	CbGeAlD
Verapamil—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000274	0.00241	CcSEcCtD
Verapamil—Myalgia—Dactinomycin—uterine cancer	0.00027	0.00238	CcSEcCtD
Verapamil—Hypersensitivity—Progesterone—uterine cancer	0.00027	0.00238	CcSEcCtD
Verapamil—SLC22A4—lymph node—uterine cancer	0.000269	0.00384	CbGeAlD
Verapamil—Rash maculo-papular—Epirubicin—uterine cancer	0.000268	0.00236	CcSEcCtD
Verapamil—Discomfort—Dactinomycin—uterine cancer	0.000267	0.00235	CcSEcCtD
Verapamil—CYP2C8—vagina—uterine cancer	0.000267	0.0038	CbGeAlD
Verapamil—Ecchymosis—Epirubicin—uterine cancer	0.000267	0.00235	CcSEcCtD
Verapamil—CYP2B6—female reproductive system—uterine cancer	0.000265	0.00377	CbGeAlD
Verapamil—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000264	0.00233	CcSEcCtD
Verapamil—Asthenia—Progesterone—uterine cancer	0.000263	0.00232	CcSEcCtD
Verapamil—Hypoaesthesia—Etoposide—uterine cancer	0.000263	0.00232	CcSEcCtD
Verapamil—Pulmonary oedema—Epirubicin—uterine cancer	0.000262	0.00231	CcSEcCtD
Verapamil—CYP2C9—female reproductive system—uterine cancer	0.000262	0.00373	CbGeAlD
Verapamil—ABCG2—female gonad—uterine cancer	0.000261	0.00372	CbGeAlD
Verapamil—Pruritus—Progesterone—uterine cancer	0.00026	0.00229	CcSEcCtD
Verapamil—ABCG2—vagina—uterine cancer	0.000259	0.0037	CbGeAlD
Verapamil—Oedema—Dactinomycin—uterine cancer	0.000259	0.00228	CcSEcCtD
Verapamil—Infection—Dactinomycin—uterine cancer	0.000258	0.00227	CcSEcCtD
Verapamil—Diarrhoea—Progesterone—uterine cancer	0.000251	0.00221	CcSEcCtD
Verapamil—Erythema multiforme—Etoposide—uterine cancer	0.00025	0.0022	CcSEcCtD
Verapamil—CYP3A4—renal system—uterine cancer	0.000249	0.00355	CbGeAlD
Verapamil—Rash maculo-papular—Doxorubicin—uterine cancer	0.000248	0.00218	CcSEcCtD
Verapamil—Ecchymosis—Doxorubicin—uterine cancer	0.000247	0.00217	CcSEcCtD
Verapamil—CYP2D6—renal system—uterine cancer	0.000245	0.0035	CbGeAlD
Verapamil—Flushing—Etoposide—uterine cancer	0.000245	0.00216	CcSEcCtD
Verapamil—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000245	0.00216	CcSEcCtD
Verapamil—Pulmonary oedema—Doxorubicin—uterine cancer	0.000243	0.00214	CcSEcCtD
Verapamil—Dizziness—Progesterone—uterine cancer	0.000243	0.00214	CcSEcCtD
Verapamil—ABCB1—myometrium—uterine cancer	0.000243	0.00346	CbGeAlD
Verapamil—CYP3A5—female gonad—uterine cancer	0.000242	0.00345	CbGeAlD
Verapamil—CYP3A5—vagina—uterine cancer	0.000241	0.00343	CbGeAlD
Verapamil—CYP2B6—vagina—uterine cancer	0.000239	0.00341	CbGeAlD
Verapamil—Vascular purpura—Epirubicin—uterine cancer	0.000239	0.00211	CcSEcCtD
Verapamil—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000238	0.0021	CcSEcCtD
Verapamil—ABCC4—lymph node—uterine cancer	0.000238	0.00339	CbGeAlD
Verapamil—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000236	0.00208	CcSEcCtD
Verapamil—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000235	0.00207	CcSEcCtD
Verapamil—Alopecia—Etoposide—uterine cancer	0.000233	0.00206	CcSEcCtD
Verapamil—Vomiting—Progesterone—uterine cancer	0.000233	0.00205	CcSEcCtD
Verapamil—Rash—Progesterone—uterine cancer	0.000231	0.00204	CcSEcCtD
Verapamil—Dermatitis—Progesterone—uterine cancer	0.000231	0.00204	CcSEcCtD
Verapamil—ABCC2—lymph node—uterine cancer	0.00023	0.00328	CbGeAlD
Verapamil—Headache—Progesterone—uterine cancer	0.00023	0.00202	CcSEcCtD
Verapamil—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000227	0.002	CcSEcCtD
Verapamil—Fatigue—Dactinomycin—uterine cancer	0.000224	0.00197	CcSEcCtD
Verapamil—Purpura—Epirubicin—uterine cancer	0.000222	0.00196	CcSEcCtD
Verapamil—Pain—Dactinomycin—uterine cancer	0.000222	0.00195	CcSEcCtD
Verapamil—Vascular purpura—Doxorubicin—uterine cancer	0.000221	0.00195	CcSEcCtD
Verapamil—Muscle spasms—Etoposide—uterine cancer	0.000221	0.00195	CcSEcCtD
Verapamil—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00022	0.00194	CcSEcCtD
Verapamil—Cardiac failure—Epirubicin—uterine cancer	0.000219	0.00193	CcSEcCtD
Verapamil—Cerebrovascular accident—Epirubicin—uterine cancer	0.000218	0.00192	CcSEcCtD
Verapamil—Lethargy—Epirubicin—uterine cancer	0.000218	0.00192	CcSEcCtD
Verapamil—Nausea—Progesterone—uterine cancer	0.000218	0.00192	CcSEcCtD
Verapamil—Diplopia—Epirubicin—uterine cancer	0.000214	0.00189	CcSEcCtD
Verapamil—Feeling abnormal—Dactinomycin—uterine cancer	0.000214	0.00188	CcSEcCtD
Verapamil—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000211	0.00186	CcSEcCtD
Verapamil—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00021	0.00185	CcSEcCtD
Verapamil—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000209	0.00184	CcSEcCtD
Verapamil—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000208	0.00183	CcSEcCtD
Verapamil—Vertigo—Etoposide—uterine cancer	0.000207	0.00182	CcSEcCtD
Verapamil—Purpura—Doxorubicin—uterine cancer	0.000205	0.00181	CcSEcCtD
Verapamil—Cardiac arrest—Epirubicin—uterine cancer	0.000203	0.00179	CcSEcCtD
Verapamil—Cardiac failure—Doxorubicin—uterine cancer	0.000203	0.00179	CcSEcCtD
Verapamil—ABCC1—lymph node—uterine cancer	0.000203	0.00289	CbGeAlD
Verapamil—Loss of consciousness—Etoposide—uterine cancer	0.000202	0.00178	CcSEcCtD
Verapamil—Cerebrovascular accident—Doxorubicin—uterine cancer	0.000202	0.00178	CcSEcCtD
Verapamil—Lethargy—Doxorubicin—uterine cancer	0.000202	0.00178	CcSEcCtD
Verapamil—CYP3A4—female reproductive system—uterine cancer	0.0002	0.00285	CbGeAlD
Verapamil—Convulsion—Etoposide—uterine cancer	0.000199	0.00175	CcSEcCtD
Verapamil—Hypertension—Etoposide—uterine cancer	0.000198	0.00175	CcSEcCtD
Verapamil—Diplopia—Doxorubicin—uterine cancer	0.000198	0.00174	CcSEcCtD
Verapamil—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000197	0.00174	CcSEcCtD
Verapamil—CYP2D6—female reproductive system—uterine cancer	0.000197	0.0028	CbGeAlD
Verapamil—Chest pain—Etoposide—uterine cancer	0.000196	0.00172	CcSEcCtD
Verapamil—Orthostatic hypotension—Epirubicin—uterine cancer	0.000195	0.00172	CcSEcCtD
Verapamil—Discomfort—Etoposide—uterine cancer	0.000193	0.0017	CcSEcCtD
Verapamil—Hypersensitivity—Dactinomycin—uterine cancer	0.000191	0.00168	CcSEcCtD
Verapamil—ABCB1—epithelium—uterine cancer	0.00019	0.00271	CbGeAlD
Verapamil—Confusional state—Etoposide—uterine cancer	0.000189	0.00167	CcSEcCtD
Verapamil—Muscular weakness—Epirubicin—uterine cancer	0.000189	0.00166	CcSEcCtD
Verapamil—ABCB1—uterine cervix—uterine cancer	0.000189	0.00269	CbGeAlD
Verapamil—KCNH2—lymph node—uterine cancer	0.000189	0.00269	CbGeAlD
Verapamil—Cardiac arrest—Doxorubicin—uterine cancer	0.000188	0.00166	CcSEcCtD
Verapamil—Anaphylactic shock—Etoposide—uterine cancer	0.000188	0.00165	CcSEcCtD
Verapamil—Infection—Etoposide—uterine cancer	0.000186	0.00164	CcSEcCtD
Verapamil—Asthenia—Dactinomycin—uterine cancer	0.000186	0.00164	CcSEcCtD
Verapamil—Influenza—Epirubicin—uterine cancer	0.000185	0.00163	CcSEcCtD
Verapamil—Tachycardia—Etoposide—uterine cancer	0.000183	0.00161	CcSEcCtD
Verapamil—Hyperhidrosis—Etoposide—uterine cancer	0.000181	0.0016	CcSEcCtD
Verapamil—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000181	0.00159	CcSEcCtD
Verapamil—Angina pectoris—Epirubicin—uterine cancer	0.00018	0.00159	CcSEcCtD
Verapamil—ABCB1—decidua—uterine cancer	0.00018	0.00256	CbGeAlD
Verapamil—CYP2D6—female gonad—uterine cancer	0.000179	0.00255	CbGeAlD
Verapamil—SLC22A5—lymph node—uterine cancer	0.000178	0.00254	CbGeAlD
Verapamil—Diarrhoea—Dactinomycin—uterine cancer	0.000177	0.00156	CcSEcCtD
Verapamil—ABCB1—renal system—uterine cancer	0.000177	0.00252	CbGeAlD
Verapamil—Hypotension—Etoposide—uterine cancer	0.000175	0.00154	CcSEcCtD
Verapamil—Muscular weakness—Doxorubicin—uterine cancer	0.000175	0.00154	CcSEcCtD
Verapamil—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000172	0.00151	CcSEcCtD
Verapamil—Influenza—Doxorubicin—uterine cancer	0.000171	0.00151	CcSEcCtD
Verapamil—Pollakiuria—Epirubicin—uterine cancer	0.000171	0.00151	CcSEcCtD
Verapamil—ABCB1—endometrium—uterine cancer	0.000171	0.00243	CbGeAlD
Verapamil—Paraesthesia—Etoposide—uterine cancer	0.000168	0.00148	CcSEcCtD
Verapamil—ABCG2—lymph node—uterine cancer	0.000168	0.00239	CbGeAlD
Verapamil—Dyspnoea—Etoposide—uterine cancer	0.000167	0.00147	CcSEcCtD
Verapamil—Somnolence—Etoposide—uterine cancer	0.000167	0.00147	CcSEcCtD
Verapamil—Angina pectoris—Doxorubicin—uterine cancer	0.000167	0.00147	CcSEcCtD
Verapamil—ABCB1—mammalian vulva—uterine cancer	0.000165	0.00235	CbGeAlD
Verapamil—Drowsiness—Epirubicin—uterine cancer	0.000165	0.00145	CcSEcCtD
Verapamil—Vomiting—Dactinomycin—uterine cancer	0.000165	0.00145	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000164	0.00144	CcSEcCtD
Verapamil—Rash—Dactinomycin—uterine cancer	0.000163	0.00144	CcSEcCtD
Verapamil—Fatigue—Etoposide—uterine cancer	0.000162	0.00143	CcSEcCtD
Verapamil—Jaundice—Epirubicin—uterine cancer	0.000161	0.00142	CcSEcCtD
Verapamil—Pain—Etoposide—uterine cancer	0.00016	0.00141	CcSEcCtD
Verapamil—Constipation—Etoposide—uterine cancer	0.00016	0.00141	CcSEcCtD
Verapamil—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000159	0.0014	CcSEcCtD
Verapamil—Sweating—Epirubicin—uterine cancer	0.000158	0.00139	CcSEcCtD
Verapamil—Pollakiuria—Doxorubicin—uterine cancer	0.000158	0.00139	CcSEcCtD
Verapamil—ABCB1—uterus—uterine cancer	0.000157	0.00224	CbGeAlD
Verapamil—Sinusitis—Epirubicin—uterine cancer	0.000155	0.00136	CcSEcCtD
Verapamil—Feeling abnormal—Etoposide—uterine cancer	0.000155	0.00136	CcSEcCtD
Verapamil—Nausea—Dactinomycin—uterine cancer	0.000154	0.00136	CcSEcCtD
Verapamil—Drowsiness—Doxorubicin—uterine cancer	0.000153	0.00134	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000151	0.00133	CcSEcCtD
Verapamil—Bradycardia—Epirubicin—uterine cancer	0.000151	0.00133	CcSEcCtD
Verapamil—Urticaria—Etoposide—uterine cancer	0.000149	0.00131	CcSEcCtD
Verapamil—Jaundice—Doxorubicin—uterine cancer	0.000149	0.00131	CcSEcCtD
Verapamil—Rhinitis—Epirubicin—uterine cancer	0.000148	0.00131	CcSEcCtD
Verapamil—Hepatitis—Epirubicin—uterine cancer	0.000148	0.0013	CcSEcCtD
Verapamil—Hypoaesthesia—Epirubicin—uterine cancer	0.000147	0.0013	CcSEcCtD
Verapamil—Pharyngitis—Epirubicin—uterine cancer	0.000147	0.00129	CcSEcCtD
Verapamil—Sweating—Doxorubicin—uterine cancer	0.000146	0.00129	CcSEcCtD
Verapamil—Oedema peripheral—Epirubicin—uterine cancer	0.000146	0.00128	CcSEcCtD
Verapamil—Sinusitis—Doxorubicin—uterine cancer	0.000143	0.00126	CcSEcCtD
Verapamil—Visual impairment—Epirubicin—uterine cancer	0.000143	0.00126	CcSEcCtD
Verapamil—ABCB1—female reproductive system—uterine cancer	0.000141	0.00201	CbGeAlD
Verapamil—Erythema multiforme—Epirubicin—uterine cancer	0.00014	0.00123	CcSEcCtD
Verapamil—Bradycardia—Doxorubicin—uterine cancer	0.000139	0.00123	CcSEcCtD
Verapamil—Hypersensitivity—Etoposide—uterine cancer	0.000138	0.00122	CcSEcCtD
Verapamil—Tinnitus—Epirubicin—uterine cancer	0.000138	0.00122	CcSEcCtD
Verapamil—Flushing—Epirubicin—uterine cancer	0.000137	0.00121	CcSEcCtD
Verapamil—Rhinitis—Doxorubicin—uterine cancer	0.000137	0.00121	CcSEcCtD
Verapamil—Hepatitis—Doxorubicin—uterine cancer	0.000137	0.00121	CcSEcCtD
Verapamil—Hypoaesthesia—Doxorubicin—uterine cancer	0.000136	0.0012	CcSEcCtD
Verapamil—Pharyngitis—Doxorubicin—uterine cancer	0.000136	0.0012	CcSEcCtD
Verapamil—Oedema peripheral—Doxorubicin—uterine cancer	0.000135	0.00119	CcSEcCtD
Verapamil—Asthenia—Etoposide—uterine cancer	0.000135	0.00119	CcSEcCtD
Verapamil—Pruritus—Etoposide—uterine cancer	0.000133	0.00117	CcSEcCtD
Verapamil—Visual impairment—Doxorubicin—uterine cancer	0.000132	0.00116	CcSEcCtD
Verapamil—Alopecia—Epirubicin—uterine cancer	0.000131	0.00115	CcSEcCtD
Verapamil—Erythema multiforme—Doxorubicin—uterine cancer	0.00013	0.00114	CcSEcCtD
Verapamil—ABCB1—female gonad—uterine cancer	0.000129	0.00183	CbGeAlD
Verapamil—Diarrhoea—Etoposide—uterine cancer	0.000128	0.00113	CcSEcCtD
Verapamil—ABCB1—vagina—uterine cancer	0.000128	0.00182	CbGeAlD
Verapamil—Tinnitus—Doxorubicin—uterine cancer	0.000128	0.00113	CcSEcCtD
Verapamil—Flushing—Doxorubicin—uterine cancer	0.000127	0.00112	CcSEcCtD
Verapamil—Dizziness—Etoposide—uterine cancer	0.000124	0.00109	CcSEcCtD
Verapamil—Muscle spasms—Epirubicin—uterine cancer	0.000124	0.00109	CcSEcCtD
Verapamil—Vision blurred—Epirubicin—uterine cancer	0.000121	0.00107	CcSEcCtD
Verapamil—Alopecia—Doxorubicin—uterine cancer	0.000121	0.00107	CcSEcCtD
Verapamil—Vomiting—Etoposide—uterine cancer	0.000119	0.00105	CcSEcCtD
Verapamil—Agitation—Epirubicin—uterine cancer	0.000118	0.00104	CcSEcCtD
Verapamil—Rash—Etoposide—uterine cancer	0.000118	0.00104	CcSEcCtD
Verapamil—Dermatitis—Etoposide—uterine cancer	0.000118	0.00104	CcSEcCtD
Verapamil—Headache—Etoposide—uterine cancer	0.000118	0.00104	CcSEcCtD
Verapamil—Vertigo—Epirubicin—uterine cancer	0.000116	0.00102	CcSEcCtD
Verapamil—Syncope—Epirubicin—uterine cancer	0.000116	0.00102	CcSEcCtD
Verapamil—Muscle spasms—Doxorubicin—uterine cancer	0.000115	0.00101	CcSEcCtD
Verapamil—Palpitations—Epirubicin—uterine cancer	0.000114	0.001	CcSEcCtD
Verapamil—Loss of consciousness—Epirubicin—uterine cancer	0.000113	0.000998	CcSEcCtD
Verapamil—Vision blurred—Doxorubicin—uterine cancer	0.000112	0.00099	CcSEcCtD
Verapamil—Convulsion—Epirubicin—uterine cancer	0.000112	0.000984	CcSEcCtD
Verapamil—Nausea—Etoposide—uterine cancer	0.000111	0.000982	CcSEcCtD
Verapamil—Hypertension—Epirubicin—uterine cancer	0.000111	0.00098	CcSEcCtD
Verapamil—Myalgia—Epirubicin—uterine cancer	0.00011	0.000967	CcSEcCtD
Verapamil—Arthralgia—Epirubicin—uterine cancer	0.00011	0.000967	CcSEcCtD
Verapamil—Chest pain—Epirubicin—uterine cancer	0.00011	0.000967	CcSEcCtD
Verapamil—Agitation—Doxorubicin—uterine cancer	0.00011	0.000965	CcSEcCtD
Verapamil—Discomfort—Epirubicin—uterine cancer	0.000108	0.000955	CcSEcCtD
Verapamil—Dry mouth—Epirubicin—uterine cancer	0.000107	0.000945	CcSEcCtD
Verapamil—Vertigo—Doxorubicin—uterine cancer	0.000107	0.000944	CcSEcCtD
Verapamil—Syncope—Doxorubicin—uterine cancer	0.000107	0.000942	CcSEcCtD
Verapamil—Confusional state—Epirubicin—uterine cancer	0.000106	0.000934	CcSEcCtD
Verapamil—Palpitations—Doxorubicin—uterine cancer	0.000105	0.000928	CcSEcCtD
Verapamil—Oedema—Epirubicin—uterine cancer	0.000105	0.000927	CcSEcCtD
Verapamil—Anaphylactic shock—Epirubicin—uterine cancer	0.000105	0.000927	CcSEcCtD
Verapamil—Loss of consciousness—Doxorubicin—uterine cancer	0.000105	0.000923	CcSEcCtD
Verapamil—Infection—Epirubicin—uterine cancer	0.000104	0.000921	CcSEcCtD
Verapamil—Shock—Epirubicin—uterine cancer	0.000103	0.000912	CcSEcCtD
Verapamil—Convulsion—Doxorubicin—uterine cancer	0.000103	0.00091	CcSEcCtD
Verapamil—Hypertension—Doxorubicin—uterine cancer	0.000103	0.000907	CcSEcCtD
Verapamil—Tachycardia—Epirubicin—uterine cancer	0.000103	0.000904	CcSEcCtD
Verapamil—Hyperhidrosis—Epirubicin—uterine cancer	0.000102	0.000896	CcSEcCtD
Verapamil—Chest pain—Doxorubicin—uterine cancer	0.000102	0.000894	CcSEcCtD
Verapamil—Myalgia—Doxorubicin—uterine cancer	0.000102	0.000894	CcSEcCtD
Verapamil—Arthralgia—Doxorubicin—uterine cancer	0.000102	0.000894	CcSEcCtD
Verapamil—Discomfort—Doxorubicin—uterine cancer	0.0001	0.000884	CcSEcCtD
Verapamil—Dry mouth—Doxorubicin—uterine cancer	9.93e-05	0.000875	CcSEcCtD
Verapamil—Hypotension—Epirubicin—uterine cancer	9.83e-05	0.000866	CcSEcCtD
Verapamil—Confusional state—Doxorubicin—uterine cancer	9.81e-05	0.000864	CcSEcCtD
Verapamil—Oedema—Doxorubicin—uterine cancer	9.73e-05	0.000857	CcSEcCtD
Verapamil—Anaphylactic shock—Doxorubicin—uterine cancer	9.73e-05	0.000857	CcSEcCtD
Verapamil—Infection—Doxorubicin—uterine cancer	9.67e-05	0.000852	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Epirubicin—uterine cancer	9.58e-05	0.000844	CcSEcCtD
Verapamil—Shock—Doxorubicin—uterine cancer	9.57e-05	0.000844	CcSEcCtD
Verapamil—Insomnia—Epirubicin—uterine cancer	9.51e-05	0.000838	CcSEcCtD
Verapamil—Tachycardia—Doxorubicin—uterine cancer	9.5e-05	0.000837	CcSEcCtD
Verapamil—Paraesthesia—Epirubicin—uterine cancer	9.44e-05	0.000832	CcSEcCtD
Verapamil—Hyperhidrosis—Doxorubicin—uterine cancer	9.41e-05	0.000829	CcSEcCtD
Verapamil—Dyspnoea—Epirubicin—uterine cancer	9.38e-05	0.000826	CcSEcCtD
Verapamil—Somnolence—Epirubicin—uterine cancer	9.35e-05	0.000824	CcSEcCtD
Verapamil—Dyspepsia—Epirubicin—uterine cancer	9.26e-05	0.000816	CcSEcCtD
Verapamil—Hypotension—Doxorubicin—uterine cancer	9.09e-05	0.000801	CcSEcCtD
Verapamil—Fatigue—Epirubicin—uterine cancer	9.07e-05	0.000799	CcSEcCtD
Verapamil—Constipation—Epirubicin—uterine cancer	8.99e-05	0.000792	CcSEcCtD
Verapamil—Pain—Epirubicin—uterine cancer	8.99e-05	0.000792	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Doxorubicin—uterine cancer	8.87e-05	0.000781	CcSEcCtD
Verapamil—Insomnia—Doxorubicin—uterine cancer	8.8e-05	0.000775	CcSEcCtD
Verapamil—Paraesthesia—Doxorubicin—uterine cancer	8.74e-05	0.00077	CcSEcCtD
Verapamil—Dyspnoea—Doxorubicin—uterine cancer	8.68e-05	0.000764	CcSEcCtD
Verapamil—Feeling abnormal—Epirubicin—uterine cancer	8.67e-05	0.000764	CcSEcCtD
Verapamil—Somnolence—Doxorubicin—uterine cancer	8.65e-05	0.000762	CcSEcCtD
Verapamil—Dyspepsia—Doxorubicin—uterine cancer	8.57e-05	0.000755	CcSEcCtD
Verapamil—Fatigue—Doxorubicin—uterine cancer	8.39e-05	0.000739	CcSEcCtD
Verapamil—Urticaria—Epirubicin—uterine cancer	8.36e-05	0.000736	CcSEcCtD
Verapamil—Pain—Doxorubicin—uterine cancer	8.32e-05	0.000733	CcSEcCtD
Verapamil—Constipation—Doxorubicin—uterine cancer	8.32e-05	0.000733	CcSEcCtD
Verapamil—ABCB1—lymph node—uterine cancer	8.27e-05	0.00118	CbGeAlD
Verapamil—Feeling abnormal—Doxorubicin—uterine cancer	8.02e-05	0.000707	CcSEcCtD
Verapamil—Hypersensitivity—Epirubicin—uterine cancer	7.75e-05	0.000683	CcSEcCtD
Verapamil—Urticaria—Doxorubicin—uterine cancer	7.73e-05	0.000681	CcSEcCtD
Verapamil—Asthenia—Epirubicin—uterine cancer	7.55e-05	0.000665	CcSEcCtD
Verapamil—Pruritus—Epirubicin—uterine cancer	7.44e-05	0.000656	CcSEcCtD
Verapamil—Diarrhoea—Epirubicin—uterine cancer	7.2e-05	0.000634	CcSEcCtD
Verapamil—Hypersensitivity—Doxorubicin—uterine cancer	7.17e-05	0.000632	CcSEcCtD
Verapamil—Asthenia—Doxorubicin—uterine cancer	6.98e-05	0.000615	CcSEcCtD
Verapamil—Dizziness—Epirubicin—uterine cancer	6.96e-05	0.000613	CcSEcCtD
Verapamil—Pruritus—Doxorubicin—uterine cancer	6.89e-05	0.000607	CcSEcCtD
Verapamil—Vomiting—Epirubicin—uterine cancer	6.69e-05	0.000589	CcSEcCtD
Verapamil—Diarrhoea—Doxorubicin—uterine cancer	6.66e-05	0.000587	CcSEcCtD
Verapamil—Rash—Epirubicin—uterine cancer	6.63e-05	0.000584	CcSEcCtD
Verapamil—Dermatitis—Epirubicin—uterine cancer	6.63e-05	0.000584	CcSEcCtD
Verapamil—Headache—Epirubicin—uterine cancer	6.59e-05	0.00058	CcSEcCtD
Verapamil—Dizziness—Doxorubicin—uterine cancer	6.44e-05	0.000567	CcSEcCtD
Verapamil—Nausea—Epirubicin—uterine cancer	6.25e-05	0.00055	CcSEcCtD
Verapamil—Vomiting—Doxorubicin—uterine cancer	6.19e-05	0.000545	CcSEcCtD
Verapamil—Rash—Doxorubicin—uterine cancer	6.14e-05	0.000541	CcSEcCtD
Verapamil—Dermatitis—Doxorubicin—uterine cancer	6.13e-05	0.00054	CcSEcCtD
Verapamil—Headache—Doxorubicin—uterine cancer	6.1e-05	0.000537	CcSEcCtD
Verapamil—Nausea—Doxorubicin—uterine cancer	5.78e-05	0.000509	CcSEcCtD
Verapamil—CYP2D6—Metabolism—STAR—uterine cancer	1.2e-05	0.000148	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—AKR1B1—uterine cancer	1.19e-05	0.000147	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—STAR—uterine cancer	1.19e-05	0.000147	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—MTHFR—uterine cancer	1.18e-05	0.000145	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—STK11—uterine cancer	1.18e-05	0.000145	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—CYP19A1—uterine cancer	1.18e-05	0.000145	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.18e-05	0.000145	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.17e-05	0.000145	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—HRAS—uterine cancer	1.16e-05	0.000144	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—MTHFR—uterine cancer	1.16e-05	0.000143	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—AKT1—uterine cancer	1.16e-05	0.000143	CbGpPWpGaD
Verapamil—ABCC1—Disease—SMAD3—uterine cancer	1.15e-05	0.000142	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—HRAS—uterine cancer	1.15e-05	0.000142	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—POLD1—uterine cancer	1.15e-05	0.000142	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.14e-05	0.00014	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—MTHFR—uterine cancer	1.13e-05	0.000139	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—RRM2—uterine cancer	1.13e-05	0.000139	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—STK11—uterine cancer	1.12e-05	0.000138	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—CYP19A1—uterine cancer	1.12e-05	0.000138	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—KRAS—uterine cancer	1.12e-05	0.000138	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.11e-05	0.000136	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—RRM2—uterine cancer	1.1e-05	0.000136	CbGpPWpGaD
Verapamil—ABCC1—Disease—FGFR2—uterine cancer	1.1e-05	0.000136	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—DCN—uterine cancer	1.1e-05	0.000135	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.09e-05	0.000134	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.09e-05	0.000134	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—AKR1C1—uterine cancer	1.07e-05	0.000132	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—DCN—uterine cancer	1.07e-05	0.000132	CbGpPWpGaD
Verapamil—ABCC1—Disease—MTHFR—uterine cancer	1.06e-05	0.00013	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.06e-05	0.00013	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.05e-05	0.00013	CbGpPWpGaD
Verapamil—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.04e-05	0.000128	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—STK11—uterine cancer	1.04e-05	0.000128	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—CYP19A1—uterine cancer	1.04e-05	0.000128	CbGpPWpGaD
Verapamil—SLC22A1—Neuronal System—HRAS—uterine cancer	1.04e-05	0.000128	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—PIK3CA—uterine cancer	1.04e-05	0.000128	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—CYP11A1—uterine cancer	1.03e-05	0.000127	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—PIK3CA—uterine cancer	1.03e-05	0.000127	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—STK11—uterine cancer	1.03e-05	0.000127	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—CYP19A1—uterine cancer	1.03e-05	0.000127	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—AKT1—uterine cancer	1.03e-05	0.000127	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—POLD1—uterine cancer	1.02e-05	0.000126	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—AKT1—uterine cancer	1.02e-05	0.000125	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—AKR1B1—uterine cancer	1.02e-05	0.000125	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—STAR—uterine cancer	1.02e-05	0.000125	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—CYP11A1—uterine cancer	1.01e-05	0.000125	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.01e-05	0.000124	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1e-05	0.000124	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—POLD1—uterine cancer	1e-05	0.000123	CbGpPWpGaD
Verapamil—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	9.96e-06	0.000123	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—TP53—uterine cancer	9.95e-06	0.000123	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—MTHFR—uterine cancer	9.84e-06	0.000121	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—AKR1C3—uterine cancer	9.76e-06	0.00012	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—PIK3CA—uterine cancer	9.74e-06	0.00012	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	9.68e-06	0.000119	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—AKR1C1—uterine cancer	9.58e-06	0.000118	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—CYP19A1—uterine cancer	9.57e-06	0.000118	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—STK11—uterine cancer	9.57e-06	0.000118	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—RRM2—uterine cancer	9.57e-06	0.000118	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—AKR1C3—uterine cancer	9.54e-06	0.000118	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—HRAS—uterine cancer	9.52e-06	0.000117	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—POLD1—uterine cancer	9.42e-06	0.000116	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—AKR1C1—uterine cancer	9.35e-06	0.000115	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—POLD1—uterine cancer	9.34e-06	0.000115	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—DCN—uterine cancer	9.29e-06	0.000115	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	8.89e-06	0.00011	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—MTHFR—uterine cancer	8.86e-06	0.000109	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—AKR1C1—uterine cancer	8.81e-06	0.000109	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CYP11A1—uterine cancer	8.75e-06	0.000108	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—AKR1C1—uterine cancer	8.74e-06	0.000108	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	8.68e-06	0.000107	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	8.6e-06	0.000106	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—RRM2—uterine cancer	8.54e-06	0.000105	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—AKT1—uterine cancer	8.46e-06	0.000104	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—PTEN—uterine cancer	8.44e-06	0.000104	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—MTHFR—uterine cancer	8.42e-06	0.000104	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—AKT1—uterine cancer	8.41e-06	0.000104	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—RRM2—uterine cancer	8.33e-06	0.000103	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—DCN—uterine cancer	8.29e-06	0.000102	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—AKR1C3—uterine cancer	8.26e-06	0.000102	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—DCN—uterine cancer	8.09e-06	9.98e-05	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—PTEN—uterine cancer	8.05e-06	9.92e-05	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—EP300—uterine cancer	8.04e-06	9.92e-05	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—PTEN—uterine cancer	7.99e-06	9.85e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—POLD1—uterine cancer	7.98e-06	9.84e-05	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—AKT1—uterine cancer	7.96e-06	9.81e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—RRM2—uterine cancer	7.85e-06	9.69e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—AKR1B1—uterine cancer	7.85e-06	9.68e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—STAR—uterine cancer	7.85e-06	9.68e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CYP11A1—uterine cancer	7.81e-06	9.63e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.81e-06	9.63e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—MTHFR—uterine cancer	7.8e-06	9.61e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—RRM2—uterine cancer	7.79e-06	9.6e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—MTHFR—uterine cancer	7.73e-06	9.53e-05	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—EP300—uterine cancer	7.67e-06	9.46e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—DCN—uterine cancer	7.62e-06	9.4e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CYP11A1—uterine cancer	7.62e-06	9.4e-05	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—EP300—uterine cancer	7.62e-06	9.4e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—STK11—uterine cancer	7.6e-06	9.38e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—CYP19A1—uterine cancer	7.6e-06	9.38e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—DCN—uterine cancer	7.56e-06	9.32e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—AKR1C1—uterine cancer	7.47e-06	9.21e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—STK11—uterine cancer	7.43e-06	9.17e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—CYP19A1—uterine cancer	7.43e-06	9.17e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.42e-06	9.15e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—AKR1C3—uterine cancer	7.38e-06	9.1e-05	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	7.27e-06	8.96e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—AKR1C3—uterine cancer	7.2e-06	8.88e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—MTHFR—uterine cancer	7.19e-06	8.87e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CYP11A1—uterine cancer	7.18e-06	8.86e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CYP11A1—uterine cancer	7.12e-06	8.78e-05	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—PTEN—uterine cancer	7.02e-06	8.66e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—ERBB2—uterine cancer	6.9e-06	8.51e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—AKR1C3—uterine cancer	6.78e-06	8.37e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—AKR1C3—uterine cancer	6.73e-06	8.29e-05	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—EP300—uterine cancer	6.69e-06	8.26e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—RRM2—uterine cancer	6.65e-06	8.21e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—PTEN—uterine cancer	6.56e-06	8.09e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—PTEN—uterine cancer	6.47e-06	7.97e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—DCN—uterine cancer	6.46e-06	7.97e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—STK11—uterine cancer	6.44e-06	7.94e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CYP19A1—uterine cancer	6.44e-06	7.94e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—CDKN1B—uterine cancer	6.39e-06	7.88e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—PTEN—uterine cancer	6.29e-06	7.76e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—EP300—uterine cancer	6.26e-06	7.72e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—EP300—uterine cancer	6.17e-06	7.6e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—POLD1—uterine cancer	6.16e-06	7.6e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CYP11A1—uterine cancer	6.09e-06	7.5e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.04e-06	7.45e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—CTNNB1—uterine cancer	6.04e-06	7.45e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—EP300—uterine cancer	6e-06	7.4e-05	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—PIK3CA—uterine cancer	5.95e-06	7.34e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—PTEN—uterine cancer	5.88e-06	7.26e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.76e-06	7.11e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—AKR1C1—uterine cancer	5.76e-06	7.1e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—AKR1C3—uterine cancer	5.75e-06	7.09e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—STK11—uterine cancer	5.75e-06	7.09e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CYP19A1—uterine cancer	5.75e-06	7.09e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—MTHFR—uterine cancer	5.71e-06	7.05e-05	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—PIK3CA—uterine cancer	5.68e-06	7e-05	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—PIK3CA—uterine cancer	5.64e-06	6.95e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—EP300—uterine cancer	5.61e-06	6.92e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—STK11—uterine cancer	5.61e-06	6.92e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CYP19A1—uterine cancer	5.61e-06	6.92e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—MTHFR—uterine cancer	5.59e-06	6.89e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PTEN—uterine cancer	5.48e-06	6.75e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.39e-06	6.65e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—STK11—uterine cancer	5.29e-06	6.52e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CYP19A1—uterine cancer	5.29e-06	6.52e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—NRAS—uterine cancer	5.25e-06	6.47e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—STK11—uterine cancer	5.24e-06	6.46e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CYP19A1—uterine cancer	5.24e-06	6.46e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—EP300—uterine cancer	5.22e-06	6.44e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.14e-06	6.34e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—RRM2—uterine cancer	5.14e-06	6.33e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—DCN—uterine cancer	4.99e-06	6.15e-05	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—PIK3CA—uterine cancer	4.95e-06	6.11e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PTEN—uterine cancer	4.93e-06	6.08e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.92e-06	6.07e-05	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—AKT1—uterine cancer	4.86e-06	6e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—MTHFR—uterine cancer	4.84e-06	5.97e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—EP300—uterine cancer	4.7e-06	5.8e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP11A1—uterine cancer	4.7e-06	5.79e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.69e-06	5.78e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PTEN—uterine cancer	4.68e-06	5.78e-05	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—AKT1—uterine cancer	4.64e-06	5.72e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—PIK3CA—uterine cancer	4.63e-06	5.71e-05	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—AKT1—uterine cancer	4.6e-06	5.68e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—PIK3CA—uterine cancer	4.56e-06	5.63e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—KRAS—uterine cancer	4.52e-06	5.57e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—STK11—uterine cancer	4.48e-06	5.52e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CYP19A1—uterine cancer	4.48e-06	5.52e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—EP300—uterine cancer	4.47e-06	5.51e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—PIK3CA—uterine cancer	4.44e-06	5.47e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—AKR1C3—uterine cancer	4.44e-06	5.47e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PTEN—uterine cancer	4.34e-06	5.35e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—MTHFR—uterine cancer	4.32e-06	5.32e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PTEN—uterine cancer	4.3e-06	5.3e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.26e-06	5.26e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—MTHFR—uterine cancer	4.21e-06	5.2e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.2e-06	5.18e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—PIK3CA—uterine cancer	4.15e-06	5.12e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—EP300—uterine cancer	4.14e-06	5.1e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—EP300—uterine cancer	4.1e-06	5.06e-05	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—AKT1—uterine cancer	4.05e-06	4.99e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.01e-06	4.94e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PTEN—uterine cancer	4e-06	4.93e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—MTHFR—uterine cancer	3.97e-06	4.9e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—MTHFR—uterine cancer	3.94e-06	4.86e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PIK3CA—uterine cancer	3.86e-06	4.76e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—HRAS—uterine cancer	3.84e-06	4.74e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—EP300—uterine cancer	3.81e-06	4.7e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.81e-06	4.69e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—AKT1—uterine cancer	3.78e-06	4.66e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—AKT1—uterine cancer	3.73e-06	4.6e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—AKT1—uterine cancer	3.62e-06	4.47e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PIK3CA—uterine cancer	3.48e-06	4.29e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.47e-06	4.28e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP19A1—uterine cancer	3.46e-06	4.26e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—STK11—uterine cancer	3.46e-06	4.26e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—AKT1—uterine cancer	3.39e-06	4.18e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—MTHFR—uterine cancer	3.36e-06	4.15e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PIK3CA—uterine cancer	3.3e-06	4.07e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PTEN—uterine cancer	3.18e-06	3.92e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—AKT1—uterine cancer	3.16e-06	3.89e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PTEN—uterine cancer	3.11e-06	3.83e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PIK3CA—uterine cancer	3.06e-06	3.77e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PIK3CA—uterine cancer	3.03e-06	3.74e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—EP300—uterine cancer	3.03e-06	3.74e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.96e-06	3.66e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—EP300—uterine cancer	2.96e-06	3.65e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—AKT1—uterine cancer	2.84e-06	3.5e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PIK3CA—uterine cancer	2.82e-06	3.48e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—AKT1—uterine cancer	2.7e-06	3.33e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PTEN—uterine cancer	2.69e-06	3.32e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—MTHFR—uterine cancer	2.6e-06	3.2e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—EP300—uterine cancer	2.57e-06	3.17e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—AKT1—uterine cancer	2.5e-06	3.08e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—AKT1—uterine cancer	2.48e-06	3.05e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PTEN—uterine cancer	2.4e-06	2.96e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PTEN—uterine cancer	2.34e-06	2.89e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—AKT1—uterine cancer	2.31e-06	2.84e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—EP300—uterine cancer	2.29e-06	2.83e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PIK3CA—uterine cancer	2.24e-06	2.77e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—EP300—uterine cancer	2.24e-06	2.76e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PTEN—uterine cancer	2.21e-06	2.72e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PIK3CA—uterine cancer	2.19e-06	2.7e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PTEN—uterine cancer	2.19e-06	2.7e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—EP300—uterine cancer	2.11e-06	2.6e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—EP300—uterine cancer	2.09e-06	2.58e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PIK3CA—uterine cancer	1.9e-06	2.34e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PTEN—uterine cancer	1.87e-06	2.31e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—AKT1—uterine cancer	1.83e-06	2.26e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—AKT1—uterine cancer	1.79e-06	2.21e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—EP300—uterine cancer	1.78e-06	2.2e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PIK3CA—uterine cancer	1.69e-06	2.09e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PIK3CA—uterine cancer	1.65e-06	2.04e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PIK3CA—uterine cancer	1.56e-06	1.92e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—AKT1—uterine cancer	1.55e-06	1.91e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PIK3CA—uterine cancer	1.55e-06	1.91e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PTEN—uterine cancer	1.44e-06	1.78e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—AKT1—uterine cancer	1.38e-06	1.71e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—EP300—uterine cancer	1.38e-06	1.7e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—AKT1—uterine cancer	1.35e-06	1.67e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.32e-06	1.63e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—AKT1—uterine cancer	1.27e-06	1.57e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—AKT1—uterine cancer	1.26e-06	1.56e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—AKT1—uterine cancer	1.08e-06	1.33e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.02e-06	1.26e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—AKT1—uterine cancer	8.32e-07	1.03e-05	CbGpPWpGaD
